Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Aktis Oncology
About AKTS
Aktis Oncology, Inc. is a clinical-stage oncology company. The Company is focused on expanding the potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The Company’s proprietary mini-protein radio conjugate platform aims to safely confer efficacy to a range of patient populations. Its mini-protein radio conjugates are designed to selectively deliver the tumor-killing properties of radioisotopes to targeted tumors with high tumor penetration and prolonged retention, while being rapidly cleared from normal organs and tissues to minimize systemic radiation exposure. Its pipeline includes AKY-1189 and AKY-2519. AKY-1189, is targeting Nectin-4 expressing solid tumors, including locally advanced or metastatic urothelial cancer, breast cancer, colorectal cancer and cervical cancer. AKY-2519 targets B7-H3 expressing solid tumors, such as prostate, lung and breast cancers.
Find out what a historical investment in Aktis Oncology would be worth today using our AKTS stock calculator.
Market Capitalisation
$1.04B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
142.84K
High today
$19.71
Low today
$18.81
Open price
$19.09
52-week high
$29.16
52-week low
$14.72
Ready to start your investing journey with Stake?
Open an accountHow do I buy AKTS shares in Australia?
Buying AKTS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Aktis Oncology in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in AKTS
What is the ticker symbol of Aktis Oncology?
The ticker symbol for Aktis Oncology is AKTS.
How much is one share of AKTS?
One share of AKTS is valued at $19.53 as of 16 May 2026.
What is the market capitalisation of Aktis Oncology AKTS?
As of 16 May 2026 Aktis Oncology has a market cap of $1.04B.
What is the 52-week high for Aktis Oncology stock?
The Aktis Oncology 52-week high stock price is $29.16.
What is the 52-week low for Aktis Oncology stock?
The Aktis Oncology 52-week low stock price is $14.72.
Can I buy AKTS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy AKTS shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in AKTS on Stake
- Buy AKTS from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of AKTS from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
AKTS related stocks